Chutes & Ladders: Merck realigns division chiefs; focuses on vaccines

Merck has realigned the positions of some of its top division chiefs as it focuses on several areas, especially the development of vaccines. Margaret McGlynn is being hustled into the president's spot of Merck Vaccines as the drug giant spurs the development of four late-stage vaccines. CFO Judy Lewent will also take on additional responsibilities in strategic planning.

- read this report from Newsday for more

Suggested Articles

The public financing will enable Monopar to start a phase 3 trial of a prophylactic treatment for a side effect of chemoradiotherapy. 

The dispute centers on whether Asa Abeliovich used Alector’s confidential information in connection with his work for Prevail Therapeutics.

GSK poaches Merck KGaA's Martinez-Davis to helm pharma stateside; Bulto named Novartis U.S. pharma head; Allergan's Saunders set for huge parachute.